Extensive Macular Atrophy with Pseudodrusen in a Japanese Patient Evaluated by Wide-Field OCTA
Extensive macular 12n/1200 wella atrophy with pseudodrusen (EMAP) is a relatively newly proposed clinical entity that was first reported in 2009.Although no definitive diagnostic criteria have been defined, characteristic findings can distinguish it from other diseases, especially dry age-related macular dystrophy (AMD).Herein, we present the case